Use of Activated Charcoal in Acute Poisoning

References

• Committee of Revision, The United States Pharmacopeial Convention, Inc. The Pharmacopeia of the United States of America18th Revision. Board of Trustees. 1970; 104–105
   Google Scholar
• Holt L. E., Jr., Holz P. H. The black bottle. J. Pediat. 1963; 63: 306
   PubMed Web of Science ®Google Scholar
• Smith R. P., Gosselin R. E., Henderson J. A., Anderson D. M. Comparison of the adsorptive properties of activated charcoal and Alaskan montmorillonite for some common poisons. Toxicol. Appl. Pharmacol. 1967; 10: 95
   PubMed Web of Science ®Google Scholar
• Phansalkar S. V., Holt L. E. Observations on the immediate treatment of poisoning. J. Pediat. 1968; 72: 683
   Web of Science ®Google Scholar
• Tsuchiya T., Levy G. Relationship between effect of activated charcoal and drug absorption in man and its drug adsorption characteristics in vitro. J. Pharm. Sci. 1972; 61: 586
   PubMed Web of Science ®Google Scholar
• Mann J. B., Sandberg D. H. Therapy of sedative overdosage. Pediat. Clin. N. Am. 1970; 17: 617
   PubMed Web of Science ®Google Scholar
• Picchioni A. L., Chin L., Verhulst H. L., Dieterle B. Activated charcoal vs. “universal antidote” as an antidote for poisons. Toxicol. Appl. Pharmacol. 1966; 8: 447
   PubMed Web of Science ®Google Scholar
• Sorby D. L., Plein E. M. Adsorption for phenothiazine derivatives by kaolin, talc, and Norit. J. Pharm. Sci. 1961; 50: 355
   Web of Science ®Google Scholar
• Corby D. G., Decker L. J. An antidote for propoxyphene HCl. JAMA 1968; 203: 1074
   PubMed Web of Science ®Google Scholar
• Chernish S. M., Wolen R. L., Rodda B. E. Adsorption of propoxyphene hydrochloride by activated charcoal. Clin. Toxicol. 1972; 5: 317
   PubMed Web of Science ®Google Scholar
• Rauws A. G., van Noordwijk J. Activated charcoal in tricyclic drug overdoses. Brit. Med. J. 1972; 4: 298
   Google Scholar
• Decker W. J., Combs H. F., Corby D. G. Adsorption of drugs and poisons by activated charcoal. Toxicol. Appl. Pharmacol. 1968; 13: 454
   PubMed Web of Science ®Google Scholar
• Chin L., Picchioni A. L., Duplisse B. R. Comparative antidotal effectiveness of activated charcoal, Arizona montmorillonite, and evaporated milk. J. Pharm. Sci. 1969; 58: 1353
   PubMed Web of Science ®Google Scholar
• Decker W. J., Corby D. G., Ibanez J. D., Jr. Aspirin adsorption with activated charcoal. Lancet 1968; 754
   PubMed Web of Science ®Google Scholar
• Picchioni A. L., Chin L., Laird H. E. Activated charcoal preparations–relative antidotal efficacy. Clin. Toxicol. 1974; 7: 97
   PubMed Web of Science ®Google Scholar
• Chin L., Picchioni A. L., Bourn W. M., Laird H. E. Optimal antidotal dose of activated charcoal. Toxicol. Appl. Pharmacol. 1973; 26: 103
   PubMed Web of Science ®Google Scholar
• Fiser R. H., Maetz V. C., Treuting J. J., Decker W. J. Activated charcoal in barbiturate and glutethimide poisoning of the dog. J. Pediat. 1971; 78: 1045
   PubMed Web of Science ®Google Scholar
• Levy G., Tsuchiya T. Effects of activated charcoal on aspirin absorption in man. Clin. Pharmacol. Therap. 1972; 13: 317
   PubMed Web of Science ®Google Scholar
• Decker W. J., Shpall R. A., Corby D. G., Combs H. F., Payne C. E. Inhibition of aspirin absorption by activated charcoal and apomorphine. Clin. Pharmacol. Therap. 1969; 10: 710
   PubMed Web of Science ®Google Scholar
• Dordoni B., Willson R. A., Thompson R. P. H., Williams R. Reduction of absorption of paracetamol by activated charcoal and cholestyramine: A possible therapeutic measure. Brit. Med. J. 1973; 3: 86
   PubMed Web of Science ®Google Scholar
• Alvan G. Effect of activated charcoal on plasma levels of nortryptyline after single doses in man. Europ. J. Clin. Pharmacol. 1973; 5: 236
   Web of Science ®Google Scholar
• Chaput de Saintonge D. M., Herxheimer A. Activated charcoal impairs propantheline absorption. Europ. J. Clin. Pharmacol. 1971; 4: 52
   PubMed Web of Science ®Google Scholar
• Tsuchiya T., Levy G. Drug adsorption efficacy of commercial activated charcoal tablets in vitro and in man. J. Pharm. Sci. 1972; 61: 624
   PubMed Web of Science ®Google Scholar
• Hartel G., Manninen V., Reissell P. Treatment of digoxin intoxication. Lancet 1973; 158
   PubMed Web of Science ®Google Scholar
• Gleason M. N., Gosselin R. E., Hodge H. C., Smith R. P. Clinical Toxicology of Commercial Products3rd ed. Williams and Wilkins, Baltimore 1969; 13
   Google Scholar
• Goodman L. S., Gilman A. The Pharmacological Basis of Therapeutics4th ed. MacMillan, New York 1970; 990
   Google Scholar
• Comstock E. G. Glutethimide intoxication. JAMA 1971; 215: 1668
   PubMed Web of Science ®Google Scholar
• Acute Poisonings. Emergency Drug Formulary. Institute of Clinical Toxicology, Houston, Texas, P.O. Box 2565, 77001
   Google Scholar
• Maragos G. D., Greene C. A., Mitchell J. R. Accidental poisoning of children in transit. J. Pediat. 1971; 79: 125
   PubMed Web of Science ®Google Scholar
• Chin L. Induced emesis. A questionable procedure for the treatment of acute poisoning. Am. J. Hosp. Pharm. 1972; 29: 877
   PubMedGoogle Scholar
• Edwards K. D. G., McCredie M. Studies on the binding properties of acidic, basic and neutral drugs to anion and cation exchange resins and charcoal in vitro. Med. J. Australia 1967; 1: 534
   PubMed Web of Science ®Google Scholar
• Nau C. A., Neal J., Stembridge V. A study of the physiological effects of carbon black. I. Ingestion. Arch. Ind. Health 1958; 17: 21
   PubMedGoogle Scholar
• Nau C. A., Neal J., Stembridge V. A study of the physiological effects of carbon black. II. Skin contact. Arch. Ind. Health 1958; 18: 511
   PubMedGoogle Scholar
• Nau C. A., Neal J., Stembridge V. A., Cooley R. N. Physiological effects of carbon black. IV. Inhalation. Arch. Environ. Health 1962; 4: 415
   PubMed Web of Science ®Google Scholar
• Yatzidis H. Activated charcoal rediscovered. Brit. Med. J. 1972; 4: 51
   PubMed Web of Science ®Google Scholar
• Matthew H. Changing patterns in the management of poisoned patients. Clin. Tox. Bull. 1972; 3: 9
   Google Scholar
• Locket S. Clinical toxicology. IV. The treatment of poisoning: What do I do first? (Part II). Practitioner 1973; 210: 575
   PubMedGoogle Scholar
• Done A. K. Emergency Med. 1971; 3: 45
   Google Scholar
• Done A. K. Emergency Med. 1971; 3: 146
   Google Scholar
• Calvert W. E., Corby D. G., Herbertson L. M., Decker W. J. Orally administered activated charcoal: acceptance by children. JAMA 1971; 215: 641
   PubMed Web of Science ®Google Scholar
• Decker W. J., Corby D. G. Activated charcoal as a gastrointestinal decontaminant: Experiences with experimental animals and human subjects. Clin. Toxicol. 1970; 3: 1
   PubMed Web of Science ®Google Scholar
• Corby D. G., Fiser R. H., Decker W. J. Re-evaluation of the use of activated charcoal in the treatment of acute poisoning. Pediat. Clin. N. Am. 1970; 17: 545
   PubMed Web of Science ®Google Scholar
• Picchioni A. L. Activated charcoal. A neglected antidote. Pediat. Clin. N. Am. 1970; 17: 535
   PubMed Web of Science ®Google Scholar
• Okun R. Treatment of sedative drug overdose. Clin. Toxicol. 1973; 6: 13
   PubMed Web of Science ®Google Scholar
• Corby D. G., Decker W. J. Management of acute poisoning with activated charcoal. Pediatrics 1974; 54: 324
   PubMed Web of Science ®Google Scholar
• Ruedy J. Acute drug poisoning in the adult. Can. Med. Assoc. J. 1973; 109: 603
   PubMed Web of Science ®Google Scholar
• Locket S. V. Evaluation of Various Forms of Treatment Administered in Poisoning. Practitioner 1973; 210: 709
   PubMedGoogle Scholar
• Levy G., Gwilt P. R. Activated charcoal for acute acetaminophen intoxication. JAMA 1972; 219: 621
   PubMed Web of Science ®Google Scholar